Figure 4. The Quantitative Determination of (a) miR-206, (b) VEGF and KRAS expression in MDA-MB-231 and MCF-7 cell lines with and without transfection with miR-206 mimic (where * significantly different from MDA-MB-231 control, ** significantly different from MCF07 control at p≤0.05)

From

VEGF and KRAS are Potential Targets of miR-206 Modulation in Triple Negative Breast Cancer

Shaymaa E. El Feky, Fawziya A.R. Ibrahim, Adel Nassar, Nadia A. Abd El Moneim, Samia A. Ebeid, Mohammad A. Ahmad, Sanaa Shawky, Mohammad M. Nasef

Journal of Cancer Research and Treatment. 2019, 7(1), 10-16 doi:10.12691/jcrt-7-1-2